Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Pacira BioSciences Inc shares valued at $95,396 were sold by SLONIN JONATHAN on Nov 17 ’25. At $24.09 per share, SLONIN JONATHAN sold 3,960 shares. The insider’s holdings dropped to 178,367 shares worth approximately $4.07 million following the completion of this transaction.
Also, SLONIN JONATHAN purchased 3,960 shares, netting a total of over 95,396 in proceeds.
Before that, Cross Shawn had sold 12,060 shares from its account. In a trade valued at $266,405, the Chief Financial Officer traded Pacira BioSciences Inc shares for $22.09 each. Upon closing the transaction, the insider’s holdings decreased to 12,060 shares, worth approximately $1.28 million.
As published in their initiating research note from H.C. Wainwright on November 17, 2025, Pacira BioSciences Inc [PCRX] has been a Buy. Analysts at Truist upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in late July. As of January 30, 2025, Truist has increased its “Sell” rating to a “Hold” for PCRX. Earlier on August 13, 2024, Truist downgraded its rating. Their new recommendation was “a Sell” for PCRX stock which previously was a “a Buy”.
Analyzing PCRX Stock Performance
On last trading session, Pacira BioSciences Inc [NASDAQ: PCRX] plunged -6.29% to $22.8. The stock’s lowest price that day was $22.77, but it reached a high of $24.92 in the same session. During the last five days, there has been a drop of approximately -3.47%. Over the course of the year, Pacira BioSciences Inc shares have jumped approximately 37.02%. Shares of the company reached a 52-week high of $27.64 on 09/03/25 and a 52-week low of $18.17 on 01/06/25.
Support And Resistance Levels for Pacira BioSciences Inc (PCRX)
According to the 24-hour chart, there is a support level at 22.06, which, if violated, would cause prices to drop to 21.33. In the upper region, resistance lies at 24.24. The next price resistance is at 25.69. RSI (Relative Strength Index) is 47.34 on the 14-day chart, showing neutral technical sentiment.
Is Pacira BioSciences Inc subject to short interest?
Stocks of Pacira BioSciences Inc saw a sharp rise in short interest on 2025-10-31 jumping by 1.0 million shares to 7.28 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 6.28 million shares. A jump of 13.7% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 13.98 of the overall float, the days-to-cover ratio (short ratio) jumped to 13.98.
Which companies own the most shares of Pacira BioSciences Inc (PCRX)?
In terms of Pacira BioSciences Inc share price expectations, FactSet research, analysts set an average price target of 25 in the next 12 months, up nearly 2.75% from the previous closing price of $24.33. Analysts anticipate Pacira BioSciences Inc stock to reach 63 by 2025, with the lowest price target being 12. In spite of this, 6 analysts ranked Pacira BioSciences Inc stock as Buy at the end of 2025. On August 12, 2024, RBC Capital Mkts assigned a price target of “a Sector perform” to the stock and downgraded coverage with a $14.
